|
|
||||||||
University of Kansas Medical Center, College of Health Sciences and Hospital, Kansas City, Kansas
Correspondence: For reprints contact: Rolf F. Barth, Dept. of Pathology and Oncology, University of Kansas Medical Center, Rainbow Blvd. at 39th St., Kansas City, Kans. 66103.
ABSTRACT
We have employed 99mTc as a radioisotopic label to study the organ distribution of murine thymocytes. The compartmentalization of 99mTc-labeled cells that had not been reduced by treatment with stannous chloride was similar to that of 51Cr-labeled cells and was characterized initially by 4850% uptake of the injected radioactivity by the lungs. Increased hepatic and splenic and decreased pulmonary localization were noted at 1 hr and these shifts were more pronounced by 4 hr. Technetium-99m-labeled cells reduced by stannous chloride had significantly different patterns of hepatic, pulmonary, and splenic localization and at 4 hr the lungs still retained 24% of the injected radioactivity compared with only 3% in the spleen. Size distribution studies revealed that unlabeled as well as unreduced and reduced 99mTc-labeled thymocytes were almost identical to one another so that differences in compartmentalization could not be attributed to this factor. Since reduction with stannous chloride did not alter the distribution of 51Cr-labeled cells, this suggested some type of complex interaction between stannous ions and the labeling species of 99mTc. The in vivo localization of intravenously administered Na99mTcO4 and Na2CrO4 was markedly different from the corresponding radiolabeled cells thereby indicating that the distribution patterns that we observed truly represented cell-associated radioactivity. Although it may not necessarily be the proper reference point, the similarity in organ distribution of 99mTc- and 51Cr-labeled cells should allow direct comparison of previously reported data employing this radionuclide and that obtained in future studies with 99mTc.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |